- Aug 10, 2018
SQZ Biotech Received $72M in Series C Funding
SQZ Biotech is a C2I alumni and one of our most successful stories. SQZ Biotech joined C2I back in December 2015 and since then, they...
- Aug 9, 2018
Current C2I Resident, Anfiro, awarded SBIR Grant from The National Science Foundation
Who are Anfiro? Anfiro is a water technology start-up that has been with C2I for a year and we are proud to have them as part of our...
- Aug 8, 2018
Frequency Therapeutics Begins Clinical Trials for Hearing Loss Drug
C2I alumni, Frequency Therapeutics, has begun to treat patients in Phase I/II clinical trials to determine the efficacy of their drug for...